Skip to main content

Together we are beating cancer

Donate now

Science & Technology

Read the latest in pre-clinical research, drug discovery and new technologies in cancer
Showing 12 out of 1507 results
Vaccine vial bottles

Researchers have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine Researchers have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine

by Sophie Wedekind | News | 22 March 2024

22 March 2024

Five lollipops in assorted colours

Dr Ruchi Gupta has been funded to continue the development of a flavoured ‘lollipop’, which could help diagnose oral cancers at earlier stages. Dr Ruchi Gupta has been funded to continue the development of a flavoured ‘lollipop’, which could help diagnose oral cancers at earlier stages.

by Yvonne Ijeh | News | 22 March 2024

22 March 2024

A Cancer Grand Challenges-branded graphic reading 'Announcing five new global Cancer Grand Challenges teams'
  • Science & Technology
  • Health & Medicine
  • Charity News

Cancer Grand Challenges gives a record £100m to five cancer research teams

Cancer Grand Challenges has awarded five research teams up to £20m each in its largest ever funding round. They will now take on four of the biggest questions in cancer.   Cancer Grand Challenges has awarded five research teams up to £20m each in its largest ever funding round. They will now take on four of the biggest questions in cancer.  

by Tim Gunn | News, Analysis | 6 March 2024

6 March 2024

Prostate Cancer cell image taken using a Scanning Electron Microscope

Research published in Cell Genomics today has shown that prostate cancer, which affects one in six men in the UK in their lifetime, includes two different subtypes of the disease, also known as evotypes. Research published in Cell Genomics today has shown that prostate cancer, which affects one in six men in the UK in their lifetime, includes two different subtypes of the disease, also known as evotypes.

by Amy Warnock | News | 29 February 2024

29 February 2024

A scientist carrying out clinical research in the lab.

Deciding to support clinical research is one of the most consequential choices a government can make. Our latest survey of the clinical research workforce uncovers what's needed to bring more potentially lifesaving treatments to patients, and to improve the NHS. Deciding to support clinical research is one of the most consequential choices a government can make. Our latest survey of the clinical research workforce uncovers what's needed to bring more potentially lifesaving treatments to patients, and to improve the NHS.

by Joe Kiely | Opinion | 12 February 2024

12 February 2024

A microscope image showing cells affected by Barrett's oesophagus, a precancer that can lead to oesophageal cancer.

For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.   For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.  

by Amy Warnock | Analysis | 9 February 2024

9 February 2024

Cells with nuclei in blue and mitochondria (energy factories) in green.

Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people. Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people.

by Tim Gunn | Analysis | 31 January 2024

31 January 2024

Two cancer researchers looking at a cell image on screen

Michelle Mitchell, our chief executive, reacts to Labour’s Life Science Plan and explains why science policy will be so important for the UK's future. Michelle Mitchell, our chief executive, reacts to Labour’s Life Science Plan and explains why science policy will be so important for the UK's future.

by Michelle Mitchell | Opinion | 30 January 2024

30 January 2024

Breast cancer cells taken as part of a biopsy shown under the microscope

New research we've funded has found that breast cancers can break down molecules in their support system to use as a source of nutrients. As healthy cells can't use this chemical pathway to make food, it could lead to a new targeted breast cancer treatment. New research we've funded has found that breast cancers can break down molecules in their support system to use as a source of nutrients. As healthy cells can't use this chemical pathway to make food, it could lead to a new targeted breast cancer treatment.

by Jacob Smith | Analysis | 17 January 2024

17 January 2024

An image of a capsule sponge, a test for Barrett's oesophagus and oesophageal cancer

Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year.  Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year. 

by Tim Gunn | Analysis | 11 January 2024

11 January 2024